Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.18 HKD | +0.39% | +0.78% | -25.11% |
13/05 | InnoCare Logs Loss in Q1 | MT |
29/03 | InnoCare Pharma Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.11% | 1.3B | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- 9969 Stock
- News InnoCare Pharma Limited
- Transcript : InnoCare Pharma Limited Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 08